BackLyra Therapeutics Overview

Lyra Therapeutics Receivables

Latest receivables for LYRA: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Lyra Therapeutics Receivables History

Loading

Lyra Therapeutics vs. peers: Receivables Comparison

Loading

Lyra Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lyra Therapeutics (LYRA) FAQ

As of the most recent data (December 2025), LYRA shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYRA's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Lyra Therapeutics is outperforming or lagging.

Tracking LYRA's receivables over time shows whether Lyra Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Lyra Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Lyra Therapeutics's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.